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The caregiver population has recently been recognized in society as a population 
highly susceptible to problems related to increased anxiety, burden, and abnormal 
psychological well-being. This experimental pretest post-test 2-group double-blind study 
was designed to measure the efficacy of cranial electrotherapy stimulation (CES) on 
anxiety and depressive symptoms of caregivers. Changes in anxiety and depressive 
symptoms were identified using pre- and posttest measures of State-Trait Anxiety 
Inventory and Beck Depression Inventory. Caregivers were assigned a pre-coded CES 
device. Neither the researcher nor the caregiver knew whether a device was active or 
sham until the completion of the entire study. This experimental design used a repeated 
measure t-test for quantitative statistics. Following an analysis of the data, the 
researcher’s hypotheses that CES would help reduce symptoms of anxiety and depression 
more significantly than a placebo were not supported. Both the treatment and control 
groups experienced decreased anxiety and depressive symptoms, but the treatment 
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Chapter 1  
Introduction 
Improvements in public health, medical advances, and the graying of the “baby 
boomer” generation have contributed to the aging of the U.S. population (Chyung, 
LePiane, Shamsy, & Radloff, 2018). Those aged 65 and older are expected to increase in 
population from 10.9 % to 15.7% from 2010 to 2050 (Colby & Ortman, 2017), an 
increase of 35 million people. Life expectancy of those aged 90 and older comprise 4.7 % 
of this older population, and this population is expected to quadruple over the next four 
decades (Colby & Ortman, 2017). In addition, more seniors are opting to remain in their 
homes longer rather than to live in skilled nursing facilities (Chyung et al., 2018). With 
these current trends, the need for caregivers will increase. However, current research has 
shown that caregivers have higher risks of adverse health and psychological effects 
because of their caregiving role (National Alliance for Caregiving [NAC], 2015). 
Additionally, few studies have investigated the effects of stress reduction interventions 
for caregivers. It was this researcher’s purpose to investigate cranial electrotherapy 
stimulation (CES) as a stress-reducing intervention for caregivers.  
Throughout the progression of providing care, caregiving transitions may lead to 
triggers for increased anxiety for caregivers (NAC, 2015). As caregivers assume their 
caregiving role, they sometimes must relinquish or modify prior responsibilities. Changes 
in family responsibility for caregivers can be stressful which could lead to dynamics in 
the family changing significantly (Lorig, Ritter, Laurent, & Yank, 2017; Schulz, & Czaja, 
2018). Additionally, the transition to a nursing home, or employing home care, may be 
difficult. Caregiver compassion can lead to distress and increased anxiety if the caregiver 




(Brooks, Fielding, Beattie, Edwards, & Hines, 2018). This distress is especially true for 
end-stage caregiving as it carries the greatest burden for caregivers. High levels of stress 
are typically associated with decisions for palliative care, life-sustaining technology, or to 
withdraw care. All these issues lead to a problem with stress for caregivers. They need 
anxiety-reducing interventions to help them deal with stressors within their caregiving 
role. 
Statement of the Problem 
In numerous studies, multiple researchers have reported that caregivers have 
higher risk of adverse health, psychological, and financial effects because of increased 
anxiety in their caregiver role (Ashley, O’Connor, & Jones, 2011; Harris, Durkin, Allen, 
DeCoster, & Burgio, 2011; King, Ainsworth, Ronen, & Hartke, 2010; MacNeil et al., 
2010; Martin et al., 2011; Pioli, 2010; Schulz, & Czaja, 2018; Turner et al., 2010). 
Researchers have conducted studies that introduce interventions to reduce anxiety and 
depressive symptoms for caregivers (Epstein-Lubow, McBee, Darling, Armey, & Miller, 
2011; Lopez, Crespo, & Zarit, 2007; Lorig et al., 2017; O'Connell, Heslop, & Fennessey, 
2010; Williams et al., 2010;). To reduce anxiety and depressive symptoms in caregivers, 
researchers in previous studies focused on two types of interventions: reduce caregiving 
time or provide information and develop coping skills (NAC, 2015). 
To date, no other research study offers a potential intervention to reduce anxiety and 
depressive symptoms in the caregiver population outside of the aforementioned two types 
of interventions. Given the body of research over the past decade for interventions, 
limitations exist in prior studies. Reducing levels of stress for caregivers does not 
necessarily reduce anxiety and depression in caregivers (Brooks et al., 2018; Gottlieb & 




care commitment may still experience anxiety and depressive symptoms regarding their 
caregiving responsibility. In addition, interventions regarding increased knowledge and 
providing coping skills also fall short in reducing stress and depression (Brodaty, Green, 
& Koschera, 2003). These types of interventions have traditionally relied on professional 
seminars and forums to disseminate information. This requires time away from 
caregiving and competes with caregivers’ already packed schedules. Due to low 
participation rates and high attrition, these types of interventions have historically not 
been very successful. Given the limitations of previous research for these types of 
interventions, it is imperative to examine alternative methods of anxiety and depressive 
symptom reduction for caregivers.  
Purpose of the Study 
This researcher sought to explore the effectiveness of cranial electrotherapy 
stimulation (CES) as an alternative treatment for caregivers to anxiety and depressive 
symptoms. A reduction in anxiety and depressive symptoms can lead to a reduction in 
caregiver burnout, the promotion of better family relations, and the experience of less 
stress and depression (Brodaty et al., 2003; Dickinson et al., 2017; Schulz, & Czaja, 
2018). Success in assisting care recipients’ sense of self-worth and increased motivation 
are also benefits in reducing stress and depression for caregivers. 
Research Questions and Hypotheses 
This study examined the following research questions:  
RQ1: Did caregivers receiving active CES treatments experience a greater 





Ho1: Participants who received active CES treatments experienced a reduction of 
anxiety as evidenced by the reduction of STAI scores against subjects in the 
CES sham group. 
RQ2: Did participants receiving active CES treatments experience a greater 
reduction of depressive symptoms as evidenced by the reduction of the Beck 
Depression Inventory (BDI) scores against subjects in the CES sham group?  
Ho2:  Participants who received active CES treatments experienced a reduction of 
depression as evidenced by the reduction of the BDI scores against subjects 
in the CES sham group. 
RQ3: Is there a relationship between anxiety symptoms and depressive symptoms 
in caregivers? 
Ho3: There is a relationship between STAI scores and BDI scores. 
Rationale and Justification of the Study 
Caregiving roles can be stressful and burdensome (Harris et al., 2011; Roth, 
Fredman, & Haley, 2015) and have all the features of chronic stress experiences. Over 
long periods of time, a caregiver role creates physical and psychological strain. Such a 
role also has high levels of uncontrollability, lacks predictability, and could create 
multiple stressors in work and family relationships. Caregiving requires high levels of 
mindfulness (Harris et al., 2011; Roth et al., 2015).  
Medical advances including home care technology, shorter hospital stays, and 
limited discharge planning, have placed increased demands on caregivers (NAC, 2015). 
However, their duties and responsibilities may be stressors in their lives that may increase 
anxiety and depression. Duties include assisting with activities of daily living (ADL) 




getting out of bed and walking. Some undertake medical duties like administering 
medication or changing dressings (NAC, 2015). Duties may also include assisting with 
instrumental activities of daily living (IADL) like supervising and monitoring the care-
recipients, as well as taking them to their appointments. Other IADLs include shopping, 
cooking, and cleaning, along with assisting with financial matters and other paperwork. 
Caregivers often provide these responsibilities around the clock while juggling other 
personal responsibilities. This may cause high levels of anxiety in caregivers that could 
lead to increased anxiety, depression, and other physical or psychological ailments. 
Anxiety is a reaction to long-term stress that has both psychological and physical 
features (McLeod, 2010). The brain works differently when it becomes anxious. Brain 
structures typically stay the same, but how the brain processes that information is 
different. Brain functioning occurs across many different parts, but with anxiety, the main 
part is the limbic striatal loop (McLeod, 2010). When this loop is in overdrive, feelings 
and emotions may seem overly important. Each part of this system plays an important 
role in anxiety, and it starts with the stress response (McLeod, 2010).  
Stress is a bio-psychological response that we experience when encountering a 
threat that we perceive we do not have adequate resources to handle (McLeod, 2010). 
Stressor are the stimulus causing the stress, e.g., caregiving role and responsibility. First, 
the body decides if a situation is stressful. If so, the hypothalamus, the part of the brain 
responsible for stress response, activates and sends a signal to the adrenal medulla and 
the pituitary gland (McLeod, 2010). Once triggered, signals are sent to the pituitary gland 
and adrenal medulla. The fight-or-flight response sends a signal through the 
sympathomedullary pathway (SAM). However, the hypothalamic pituitary-adrenal 




When a stressor activates the HPA, the pituitary gland is stimulated by the 
hypothalamus and secretes adrenocorticotropic hormones (ACTH). These hormones 
produce cortisol, which enables the body to sustain the steady supply of blood sugar 
needed to cope with continued stressors (McLeod, 2010). During this process, the 
immune system is suppressed. Sustained levels of cortisol due to chronic stress can lead 
to unhealthy bone and muscle structure. High, sustained levels of cortisol may (a) slow 
normal cell regeneration and healing, (b) reduce the biochemical necessary to making 
vital hormones, (c) impair digestion and metabolism, (d) diminish mental functioning, (e) 
interfere with endocrine functions, and (f) weaken the immune system (McLeod, 2010).  
Caregiver anxiety is the state of long-term chronic stress due to caregiving roles 
and responsibilities (McLeod, 2010). Some caregivers face years or decades of 
caregiving responsibility. Increased stress may persist if there is no hope that the care-
recipient is getting better. Without support and adequate interventions, the stress of 
caregiving may leave caregivers to a wide range of physical, psychological, and 
emotional problems, ranging from heart disease and depression to death (Jain, 2014). 
Caregivers who provide care for dementia care recipients are 63% more likely to have an 
increased risk of death because related to their caregiving role than any other type of 
caregiver (Tremont, 2011).  
Limitations  
Research methodologies have limitations (Krathwohl, 2009). Researchers should 
be able to recognize and determine if the benefits outweigh the cost of the study 
(Krathwohl, 2009). The researcher identified the following limitations that may reduce 
efficacy of treatment and of identified solutions. A limitation is the possibility there will 




participants from the Houston area. Due to caregiving work schedules, there may be a 
lack of available caregivers willing to participate. Additionally, there may be constraints 
because CES may seem uncomfortable to some caregivers or they may not have interest 
in the study. Another limitation is that some participants may not complete the full 21-
day protocol for using the CES device.  
Definitions of Terms 
The following definitions enhance the understanding of this study.  
Anxiety symptoms. The uneasy feelings with apprehension from a real or 
perceived threat of imminent danger (McLeod, 2010). In this study, caregiver anxiety 
symptoms were measured using STAI scores.  
Caregiver. The two types of caregivers are formal and informal. Formal 
caregivers are paid or volunteer and provide care through service systems that include 
non-profit or for-profit home care agencies, assisted living facilities, intermediate care 
facilities, nursing homes, community services, hospice organizations, churches, or charity 
service groups (NAC, 2015). Informal caregivers include family members, friends, and 
neighbors who provide unpaid caregiving services out of friendship, love, respect, or 
obligation, to disabled or chronically ill individuals (NAC, 2015). In this study, the term, 
“caregiver” were used to reflect both informal and formal caregivers over the age of 18.  
Cranial electrotherapy stimulation (CES). Introduced to the United States of 
America over 50 years ago, CES is “any small electrical current that is passed across the 
head for therapeutic purposes” (Kirsch, 2002, p. 3). Other names found in the literature 
for CES are electrosleep, transcranial electrical stimulation, or cerebral 
electrostimulation (Kirsch, 2002). In this study, CES devices, known as Alpha-Stim, 




Depressive symptoms. Feelings of intense sadness, including helplessness, and 
feeling hopeless or worthless (Beck, Steer, & Garbin, 1988). These feelings may last 
from many days or weeks to several months (Beck et al., 1988). They may also keep one 
from functioning normally. In this study, caregiver depressive symptoms were measured 






















Chapter 2  
Literature Review 
Caregivers are a critical resource to national healthcare. However, the current 
body of research and clinical observation has shown that assuming a caregiving role can 
increase anxiety that may cause adverse health effects (Ashley et al., 2011; Harris et al., 
2011; King et al., 2010; Lockenhoff, Duberstein, Friedman, & Costa, 2011; MacNeil et 
al., 2010; Martin et al., 2011; Pioli, 2010; Turner et al., 2010; Wooden, 2013). Physical 
and psychological strain occurs over time, with caregiving, accompanied by high levels 
of unpredictability and uncontrollability. Such strain can create secondary stress across 
work and family relationships (Schulz & Sherwood, 2008).  
Formal Versus Informal Caregivers 
There are two types of caregivers: informal and formal. Known as home care 
workers, home health aides, or personal care aides, formal caregivers are increasingly in 
demand as the older population increases (U.S. Bureau of Labor Statistics [BLS], 2016). 
Families of loved ones needing care are hiring formal caregivers to provide in-home care. 
Formal caregivers help those who are disabled, chronically ill, or cognitively impaired 
and need assistance (BLS, 2016). The employment rate of formal caregivers is expected 
to increase to 69% by 2020. The BLS (2016) reported that formal caregiver positions are 
growing faster than most occupations. However, this high demand does not translate into 
high wages for formal caregivers. In practice, formal caregiver occupations are among 
the lowest paid occupations in the nation (BLS, 2016). In some states, wages fall below 
the federal poverty line. Of the 2.5 million formal caregivers in the U.S., most are 
disproportionately female immigrants or women of color and on public assistance like 




In contrast, informal care giving is unpaid and provided by a family member, 
friend, or neighbor out of love, respect, or obligation (Chyung et al., 2018)). This type of 
caregiver outnumbers formal caregivers. Estimates for total number of informal 
caregivers range from 20 to 50 million people. This number represents 20% of the 
population providing full or part-time care (NAC, 2015). Colby and Ortman, (2017) 
reported that the typical informal caregiver is a female in her mid-40s with a full-time 
job. This type of caregiver provides care for an average of 18 hours a week.  
Among informal caregivers aged 20 to 75, 38% care for parents while 11% care 
for their spouse (BLS, 2016). Two-thirds of caregivers who care for people 50 years old 
or older and who work part-time or full-time reported rearranging their work schedule, 
decreasing hours, or taking unpaid leaves to meet caregiving responsibilities (NAC, 
2015). A recent study estimated that informal caregivers have lost about $660,000 in 
wages over their lifetime due to work sacrifices (Chyung et al., 2018). The loss of 
productivity to businesses due to caregivers taking time off is between 11 and 29 billion 
dollars yearly. Informal caregivers’ mean time to provide care is approximately 4.5 years; 
however, at least 20% are providing care five years or longer (NAC, 2015).  
A progression of care commitment exists between informal and formal caregivers. 
That progression is through intermittent, part-time, and full-time care. As caregiving 
needs increase in intensity along with the number of hours required for care, the need for 
formal caregiving increases. This in part is due to their training – or lack of training – to 
address certain situations within their caregiving role. However, some informal 
caregivers are unwilling to stop providing care for their loved one or family member even 
when caregiving needs increase, and fail, or are unwilling, to realize they have reached 




may recognize the need for formal care, but the money does not exist to pay for it (NAC,  
2015). This type of overload can cause increased anxiety, depression, or physical 
ailments regardless of the level of commitment necessary when providing intermittent, 
part-time, or full-time care.  
Informal caregivers providing intermittent care give occasional attention to 
patients who are still living in their home. These caregivers would typically live or work 
close by and would stop by for occasional visits. Although the care is intermittent, a level 
of daily stressors still exists because of the caregiving role.   
Caregivers may provide part-time care if no extensive medical condition exists. In 
this type of care, the care-recipient and informal caregiver usually live together. The 
caregiver maintains a consistent work schedule while providing care. However, levels of 
anxiety and stressors can still affect the caregiver. Caregivers who provide full-time care 
often live with the care-recipient. Both informal and formal caregivers can provide this 
type of care. Due to the demands of this type of care, caregivers often suffer depression, 
social isolation, and other possible physical ailments (NAC, 2015). Usually during this 
point in the progression of commitment, the caregiver must decide whether to go 
completely with formal care or continue with informal care. These transitioning times are 
also stressors for caregivers (NAC, 2015). To fully understand the effects of the 
caregiving role on caregivers, one must have a basic understanding of the history of stress 
and anxiety research. 
Pioneers of Stress and Anxiety Research 
During the early twentieth century, Walter Cannon, a Harvard Medical School 
psychologist, and physiologist, first described the body’s reaction to stress (Cannon, 




noticed changes in their stomach function when the animals were frightened or scared 
(Cannon, 1932). Cannon continued to study physiological reactions to stress in the body 
and identified the stress reaction as the fight or flight response. This reaction is also 
known as acute stress response (Cannon, 1932). Cannon defined fight or flight response 
as the body preparing itself when facing a threat; it either stands ground and fights or runs 
away (Cannon, 1932). 
The endocrinologist Selye (1975) first defined stress as the body’s nonspecific 
response to demands made upon it. While observing changes in the body of lab rats 
exposed to stressors, stress reactivity was summarized as general adaptation syndrome, a 
three-phase process. Selye called the first phase the alarm reaction, explaining that in this 
phase the body begins to show changes that are characteristic of exposure to a stressor. 
Simultaneously, the body’s resistance to handle the stressor diminishes. Stressors that are 
significantly strong, like extreme temperature, can ultimately cause death. Selye called 
the second phase the state of resistance. In this phase, the body adapts to the exposure of 
the stressor and resistance maintains. The bodily changes characteristic of exposure to the 
stressor have disappeared and levels of resistance rise above normal (Selye, 1975). 
Selye (1975) described the third stage of stress reactivity exhaustion. In this 
phase, the body is no longer able to adjust or adapt to the long-term exposure of the 
stressor. As a result, signs of the alarm reaction reappear, but this time the signs are 
irreversible. Selye explained that stress can result from a good experience, like a 
promotion, or from a bad experience, like a loss of a loved one. Both are experienced 
physiologically, and we must learn how to adapt (Selye, 1975). Cannon (1932) and Selye 




Other researchers have added to Selye and Cannon’s body of research to 
illuminate how the body handles stress. One such scientist was Simeons (1961), who was 
responsible for the link between stress and psychosomatic illness. Simeons (1961) 
theorized that stress is due to a lack of inner peace. The neurologist Harold Wolf (1953) 
contributed his understanding of the connection between the nervous system and diseases 
like ulcers, colitis, and hypertension. He was first to establish a separate category of 
illness he defined as psychosomatic. Cardiologists Friedman and Rosenman (1958) 
developed their theory while observing patients with heart conditions while in the waiting 
room of their office. Some of their patients were unable to sit for long periods of time but 
rather sat on the edge of their seats and leapt up frequently. 
Friedman and Rosenman (1958) went on to label this behavior as Type A 
personality. People with Type A personality had a higher risk of heart disease and high 
blood pressure than other personality types (Friedman & Rosenman, 1958). Simonton, 
Matthews-Simonton, and Sparks (1980) developed a model for the emotional support of 
cancer patients. They introduced the concept that a positive state of mind could influence 
one’s ability to survive cancer. Cardiologists Benson and Klipper (1975) pioneered mind-
body medicine when they introduced spirituality and healing into medicine. Psychiatrists 
Holmes and Rahe (1967) examined the medical records of patients to determine if 
stressful events caused illnesses and found 43 life events that were based on a relative 
score. A positive correlation was found between their patients’ life events and illnesses. 
Those results were published as the Holmes and Rahe Stress Scale (1967).  
The link between stress and illness may explain why caregivers’ experience 
adverse health effects in their caregiving role, as caregivers certainly experience stress in 




times. This lack of clarity is even found in the 2013 edition of the APA’s DSM-V. One 
such reason is that the DSM-V has approximately 13 different diagnoses categorized 
under anxiety disorder. In addition, there is overlap of symptoms between each diagnosis. 
Another reason is that the two words are often interchangeable in the DSM-V. McLeod 
(2010) found that symptoms of stress include headache, chest pain, increased blood 
pressure, muscle aches, and shortness of breath, to name a few. The DSM-V lists 
symptoms of stress for a panic attack as “palpitations, heart pounding, sweating, 
trembling, shortness of breath, choking feeling, chest pain” (p. 432). Although the 
symptoms are similar, they require different diagnoses. Stress is typically short-term and 
resolved when the causing stressor is removed. In contrast, anxiety symptoms are usually 
long-term and remain after the causing stressor is removed. Stress is the body’s physical 
response to events and circumstances, whereas anxiety is the uneasy feeling regarding 
apprehension from threat or imminent danger (Mayer, 2011). Mayer’s definition would 
further imply that stress can lead to anxiety.  
Caregiving touches almost every family in different ways. It is, therefore, 
important to have interventions that reduce anxiety and depression in caregivers. To find 
possible interventions, it would be helpful also to understand the physiological aspects. 
To further understand how the body processes anxiety, one must first understand 
neurotransmitters – the brain elements that comprise the brain messaging system.  
Neurotransmitters 
Neurotransmitters are chemicals in the brain that convey information throughout 
the brain and body and signal nerve cells to tell the heart to beat, the lungs to breathe, and 
the stomach to digest, as well as other body functions (Neurogistics, 2014). 




Neurotransmitters can cause unfavorable symptoms when out of balance (Neurogistics, 
2014). In addition, stress can cause neurotransmitter levels to be out of their most 
efficient range. The neurotransmitters responsible as stress indicators are: Epinephrine, 
Norepinephrine, Dopamine, Serotonin, GABA, Glutamate, and PEA (Neurogistics, 
2014). 
Researchers place neurotransmitters into two categories: inhibitory and excitatory. 
Inhibitory neurotransmitters-serotonin, GABA, and dopamine-help calm the brain by 
preventing excitatory neurotransmitters from over stimulating the brain (Neurogistics, 
2014). Excitatory neurotransmitters—dopamine, norepinephrine, epinephrine, and 
glutamate—stimulate the brain and are responsible for many stimulatory processes in the 
body (Neurogistics, 2014). When any of these neurotransmitters fall above or below 
optimal levels, adverse health symptoms can occur (Neurogistics, 2014). Table 1 shows 
clinical correlations of specific neurotransmitters to indications of stress and anxiety 
when the neurotransmitters are not at optimal levels. 
Chronic stress and anxiety increase the level of excitatory neurotransmitters in the 
body. In response, the brain increases inhibitory neurotransmitters levels to bring balance 
to neurotransmitters levels. When stress and anxiety persist, increased levels of inhibitory 
neurotransmitter response may be inadequate to regain balance (Neurogistics, 2014). In 
such cases, additional neurotransmitter support through diet or dietary supplements may 
be indicated. If the balance is not restored, risks for complicating health issues and 





Neurotransmitter Clinical Correlations for Specific Disease State 
Neurotransmitter High Levels Low Levels 
Epinephrine 
(adrenaline) 
Anxiousness, focus and 
concentration issues, sleep 
difficulties  
Focus and concentration 
issues, fatigue, low libido, 
weight issues 
Norepinephrine Anxiousness, focus and 
concentration issues, low 
mood, pain, sleep 
difficulties, weight issues 
Focus and concentration, 
low mood, fatigue, low 
libido, memory issues, 
weight issues 
Dopamine Focus and concentration 
issues, sleep difficulties 
 
Urges, impulsivity, 
cravings, anxiousness, focus 
and concentration issues, 
low mood, fatigue, low 
libido, memory issues 
Serotonin Intestinal complaints, low 
libido 
 
Anxiousness, low mood, 
intestinal complaints, low 
libido, pain, sleep 
difficulties, weight issues 





Glutamate Urges, cravings, focus and 
concentration issues, low 
mood, intestinal complaints, 
pain, sleep difficulties, 
weight issues 
Fatigue, focus and 
concentration 
PEA Sleep difficulties, mind 
racing, anxiousness 
Focus and concentration 
issues, fatigue, memory 
issues, weight issues, 
difficulty thinking clearly 





Prevalence of Caregiving in the United States 
The National Alliance for Caregiving (2015) in collaboration with the American 
Association of Retired Persons (AARP) conducted a study to present a portrait of 
caregivers in the United States. The three-part study series examined caregiving trends. 
The first phase of the study took place in 2004 and had a core focus on care-recipients. 
The second and third phases of the study took place in 2009 and 2015. The later phases 
focused more on caregivers and their caregiving role. For purposes of this study, the 
researcher will only use findings from the 2009 and 2015 phases because the findings of 
those phases align more with the research goals of this study.  
Under the direction of  Naiditch and Weber-Raley (2009), the core research areas 
examined in the 2009 and 2015 were demographic characteristics of caregivers; 
caregiving situation regarding responsibilities, intensity, and duration of care; and the 
effect of the caregiver role on their personal life and health. Quantitative interviews were 
conducted nationwide with 1,480 (N = 1,480) caregivers in 2009 and 1,248 (N = 1,248) 
caregivers in 2015. Naiditch and Weber-Raley (2009) explained that comparisons should 
not be drawn between the 2009 and 2015 findings. Although the 2015 study builds itself 
from prior research phases, it was conducted during a technological shift requiring online 
data collection. Prior research phases conducted data collection utilizing landline 
telephones only. The researchers concluded that the 2009 and 2015 findings should be 
viewed as isolated studies showing the prevalence of caregiving in the United States 
without drawing comparisons. Table 2 shows the key findings in the 2009 and 2015 





Key Demographic Findings  
 2009 Study 2015 Study 
Gender   
           Male 34% 40% 
           Female 66% 60% 
Age   
           18 to 34 22% 23% 
           35 to 49 29% 23% 
           50 to 64 35% 34% 
           65 to 74   9% 12% 
           75 or older   4%   7% 
Race / Ethnicity   
           White 72% 62% 
           African-American 13% 13% 
           Hispanic 12% 17% 
           Asian-American   2%   6% 
           Other   1%   2% 
Marital Status   
           Married 58% 57% 
           Living with partner   5%   8% 
           Single, never married 16% 19% 
           Separated, divorced 14% 9% 
           Widowed   7% 7% 
Caregiver Household Income   
           Less than $49,999 42% 47% 
           $50,000 to $99,999 61% 30% 
           $100,000 or more 19% 23% 
Employment Status   
           Employed providing care 57% 60% 
           Not employed providing care 43% 40% 
Duration of care provided   
           Less than 6 months 16% 31% 
           6 months to 1 year 18% 19% 
           1 to 4 years 33% 27% 
           5 to 9 years 13% 13% 
           10 years or more 20% 10% 
  
(National Alliance for Caregiving, 2015) 
 
Caregiver Roles Across Different Care Recipient Diagnoses 
Caregiving experiences vary with the type of illness, disorder, or disability of the 




all possible caregiving experiences. The NAC (2015) identified three distinct illness 
categories for people with progressive chronic illness: “gradual decline, steady 
progression followed by a relatively clear short-lived terminal phase, and gradual decline 
punctuated by brief episodes of accelerated decline followed by some recovery” (NAC, 
2015, p. 4). These three categories are illness trajectories described for people with 
chronic illness. Common chronic illnesses are Alzheimer, cerebrovascular accident, 
cancer, congestive heart failure, and HIV/AIDS. Each of these illnesses impact the 
characteristics of the care given by a caregiver. 
Prolonged Gradual Decline 
Alzheimer’s Disease and Related Disorders. Most research studies focus on 
caregivers for Alzheimer’s disease or related disorders (ADRD). Of the four million 
Americans living with ADRD, three million live at home (NAC, 2015). Alzheimer’s 
cases are expected to reach 13.2 million by the year 2050. Caregiving for dementia is the 
most difficult and time-consuming of all the types of caregiving. Twenty-four percent of 
caregivers of dementia patients work upwards of 40 hours per week versus 16% of 
nondementia caregivers (NAC, 2015). 
Caregivers of dementia patients are under more stress, and spend less time 
socializing with family and friends, than any other caregiver. This is largely due to the 
“cognitive impairment, neuropsychiatric abnormalities, dysphoria, disinhibition, 
delusions, and problematic behavior” that is typical with the disease (NAC, 2015, p. 8). It 
was also found that caregivers of dementia patients have worse emotional and physical 
health than caregivers for other illnesses (NAC, 2015). 
Cerebrovascular Accident (CVA) or Stroke. In the United States, nearly 




Association, 2018). Survivors are usually dependent on long-term care. In fact, the NAC 
(2015) reported stroke as the leading cause for long-term disability. The sudden 
unexpected nature of strokes rarely leaves much time for preparing for caregiving roles. 
Due to this sudden onset, caregivers often feel a lack of support from others. High 
caregiving demands for this type of patient, mixed with caregivers feeling a lack of 
support, can negatively impact their mental and physical health (Low, Payne, & 
Roderick, 1999). 
Steady Progression Followed by a Short-Lived Terminal Phase: Cancer 
Cancer is the second leading cause of death in the United States (NAC, 2015). 
Although cancer treatment has advanced, the five-year survival rate for all cancers is only 
65% (Edwards et al., 2014). As with caregivers of patients with chronic disabilities, 
cancer caregivers are at risk for psychological morbidity. Researchers found the rates of 
depression of cancer caregivers increase from 20% when newly diagnosed to 50% when 
the patient is terminally ill (Sherwood et al., 2008; Tomarken et al., 2008). 
Cancer caregiving varies depending on the stage of illness. These stages include 
diagnosis, treatment, remission, or palliative care. Caregivers typically try to obtain 
information about the disease after diagnosis but are usually ignored by health care 
providers (Rees & Bath, 2010). In the treatment phase, caregivers focus less on their own 
needs and more on the needs of the patient for support. They also attempt to obtain 
information on treatment procedures, side effects, and prognosis (Luker, Beaver, 
Leinster, & Owens, 1996). During remission, caregiver stress decreases (Northouse, 
Mood, Templin, Mellon, & George, 2010). However, a recurrence of the illness causes 




palliative phase demands more extensive personal care causing caregivers depression and 
burdens to increase while their quality of life decreases (Grunfeld et al., 2011).  
Pain is a major concern in cancer patients (McGuire, 2009). Although there have 
been advances in treatment, 70% of patients with a terminal illness experience pain 
(McGuire, 2009). Pain is viewed as a precursor to physical deterioration. Because of this 
pain, caregivers report working with cancer patients as the most stressful human 
experience (Powe & Finnie, 2003). This type of caregiver has higher levels of depression 
and mood disturbances than those caregivers with pain-free patients (Hasson-Ohayon, 
Goldzweig, Braun, & Gallinsky, 2010). In addition, caregivers deal with fears of patient 
medication addiction and side effects (Hasson-Ohayon et al., 2010). 
Gradual Decline With Brief Episodes of Accelerated Decline and Some Recovery 
Congestive Heart Failure (CHF). Patients with severe CHF have the worse 
quality of life of all chronic diseases; however, two-thirds of CHF hospitalizations are 
preventable (Juenger et al., 2002). The researchers stated that patients do not follow 
medical advice or do not seek help when symptoms occur. Strong relationships between 
caregivers and patients decreases the number of readmissions (Juenger et al., 2002). 
Empowering caregivers and allowing them to take part in discharge planning makes them 
more accepting of the caregiving roles (Bull, Hansen, & Gross, 2000).  
HIV/AIDS. The introduction of better medication has transformed acquired 
immune deficiency syndrome (AIDS) from a rapid progressive illness to a chronic illness 
(Welch & Morse, 2012). This improved survival rate results in a greater need for more 
informal caregivers and palliative care. Patient and caregiver deal with comorbid diseases 
like chronic obstructive pulmonary disease, diabetes, hypertension, and congestive heart 




for a person living with HIV/AIDS (PLHA). This principle states that contact among 
similar people occurs more often than between dissimilar people (McPherson, Smith-
Lovin, & Cook, 2001). Seventy-five percent of HIV/AIDS patients are men. As a result, 
over half of PLHA caregivers are men when compared to caregivers of other illnesses 
(Centers for Disease Control and Prevention [CDC], 2016; NAC, 2015).  
HIV is more common with ethnic minorities, IV drug users, and the poor (CDC, 
2016; Karon, Fleming, Stekette, & DeCook, 2010). The CDC (2016) reported that 70% 
of newly diagnosed cases are nonwhite. Because of the limited resources for receiving 
formal care services available to nonwhites, ethnic minority caregivers provide the most 
intensive AIDS care (Turner, Catania, & Gagnon, 2013). Twenty percent of cases are IV 
drug users (CDC, 2016). It is typical for drug abusers to deplete their own resources and 
be supportive of other’s emotional and financial resources. As a result, drug abusers are 
more likely to rely on friends rather than family for caregiving (NAC, 2015). Burden for 
this type of caregiver is increased because the caregiver often does not have legal rights 
or benefits (NAC, 2015).  
The CDC (2016) reported that AIDS is prevalent in youth and a leading cause of 
death among 25 to 44-year olds. As a result, parents or those acting as surrogates for 
minor children typically are the caregivers. However, since HIV/AIDS is unfortunately a 
highly stigmatizing disease, caregivers may perceive stigma as guilt by association. They 
may find themselves unwilling to disclose the patient’s diagnosis or the prevalence of 
disease to avoid unwanted social reactions. In addition, they may feel socially distant 
from family and friends when support is needed. They may even delay their own medical 





Additional caregiving roles of care recipients not included in the body of literature 
would include those with a severe mental health diagnosis including Autism Spectrum 
Disorder. As with AIDs, caregivers providing for this type of care recipient are typically 
informal caregivers due to the stigma placed on those with mental health issues 
(Saunders, 2013). Sometimes even the caregiver themselves feel marginalized and the 
stigma placed on them. Often, they too feel inadequate or unprepared to handle the 
episodic stressors that come with their caregiving role (Saunders, 2013). 
Regardless of the illness cared for, caregiver outcomes have individual 
differences. The stress process model explains these differences as that model has 
identified risk and protective factors (Pioli, 2010). The components of the stress process 
model are primary stressors, secondary stressors, and appraisal (Pioli, 2010). 
Caregiver Stressors That May Lead to Increased Anxiety  
Primary stressors include those stressors that directly impact the caregivers’ 
physical well-being. Stressors include the severity of patient illness and the required 
physical task necessary to render the specific care. Caregivers typically help patients with 
activities of daily living (ADL) (BLS, 2016). These include bathing, dressing, grooming, 
eating, toileting, and transferring patients from bed or chair. In some cases, they 
additionally provide instrumental activities of daily living (IADL) like food shopping, 
meal preparation, housework, and transportation (BLS, 2016). The BLS (2016) also 
stated that 15% of all caregivers administer medications and change dressings.    
Patient suffering also impacts caregiver well-being (Papastavrou et al., 2011). 
Researchers found that caregiver perception of patient suffering contributes to caregiver 




changes in patient suffering were associated with caregiver’s depression and burdens 
(Papastavrou et al., 2011). Compassion derives from a sense of shared suffering coupled 
with the caregiver’s desire to help alleviate it. Compassion can cause distress if the 
caregiver feels an inability to relieve the patient’s suffering (Papastavrou et al., 2011). 
Primary stressors typically overlap into a second set of stressors that include 
feelings of being underappreciated, social, and financial pressures, and transitions. The 
BLS (2016) reported that 62% of caregivers are married or have a live-in partner, 59% 
have additional jobs, and 37% are parents who are raising children. These demands often 
conflict with providing care for patients because of conflicting roles and challenging 
demands. In addition, researchers found that caregivers report they have no time to 
socialize and incur substantial financial responsibility. Preoccupation with financial 
obligations may cause caregivers to be less attentive to patient care (Jardim & Pakenham, 
2009). 
Caregiving transitions are also stressors for caregivers (Jardim & Pakenham, 
2009). For example, as the dynamics of care changes so does caregiving responsibilities. 
With changing responsibilities, caregivers relinquish or modify their roles that can often 
lead to greater challenges for other family members and friends (Jardim & Pakenham, 
2009). Caregivers of dementia patients are at risk for depression following their patient’s 
nursing home placement, as the caregiving role does not end (MacNeil et al., 2010). 
Caregivers continue to visit the patient and may provide physical care during those visits. 
Poor communication and negative interactions with nursing home staff can have an 
impact on caregivers’ well-being (MacNeil et al., 2010). Additionally, end-stage 
caregiving often thrusts caregivers into their greatest burden. The NAC (2015) reported 




hospice patients. Furthermore, they typically handle decisions dealing with life-sustaining 
technology. 
In addition to primary and secondary stressors, appraisals impact caregiving 
outcomes. Appraisals are how caregivers handle or react to stressors. It plays a greater 
role in their well-being than primary or secondary stressors (Haley et al., 2011). As they 
perform their caregiving, caregivers are constantly appraising the impact and demand on 
themselves and judging whether their resources are adequate to cope with that impact. 
Emotional and behavioral responses are created that can contribute to health outcomes 
(Haley et al., 2011). Additionally, the ethnicity of the caregiver can affect those health 
outcomes.  
Ethnic differences exist in appraisals. Researchers found that African American 
caregivers report more positive caregiving and less stress than other ethnicities (Chyung 
et al., 2018). Because they were not found in noncaregivers, they also found that 
appraisal differences due to ethnicities are specific to caregivers. Factors such as 
motivation for providing care, coping strategies to deal with caregiving experiences, and 
greater availability for support all play a part in these differences (Chyung et al., 2018). 
Researchers also found ethnic differences in attitudes toward caregiving that affected 
appraisals (Pinquart & Sorensen, 2005). Western cultures value individualism, whereas 
non-western cultures value collectivism such as familism (Pinquart & Sorensen, 2005). 
Compared to White caregivers, African American and Hispanic caregivers generally 
report a stronger caregiving ethic and cultural reasons for caregiving (Pinquart & 
Sorensen, 2005). 
Although a greater network of support implies greater availability of resources, 




distress (Pinquart & Sorensen, 2005). Latino caregivers report less support is available to 
them than White caregivers because they are less willing to ask for advice or discuss their 
feelings with their support network (Pinquart & Sorensen, 2005). These kinship networks 
could be a barrier to seeking formal caregiving if the family keeps problems, they 
consider to be potentially embarrassing to the family, to themselves. 
Although differences in caregiving outcomes depend on the interaction between 
caregiver and recipient, studies show caring for individuals with an illness contributes to 
psychiatric and physical morbidity. Pinquart and Sorensen (2005) found that caregivers 
experience more stress, depression, and lower well-being than non-caregivers. 
Additionally, differences were significant for spousal caregivers and women. Researchers 
found spousal caregivers to have worse outcomes because they provide higher intensity 
hands-on care. Additionally, women are at higher risk because they are more conscious 
of their emotions, tend to be more sympathetic, and are willing to report negative feelings 
(Baider & Bengel, 2010). 
Providing care for others may influence physical health (Pinquart & Sorensen, 
2005). Caregivers may ignore self-care needs and not engage in preventative health 
behaviors (Schulz & Sherwood, 2008). Additionally, researchers found that caregiver 
chronic stress may compromise immunity to disease, cardiovascular reactivity, wound 
healing (Schulz & Sherwood, 2008). Schulz and Sherwood (2008) found there to be a 
63% higher mortality risk in caregivers than non-caregivers.  
Depression Among Caregivers 
Multiple studies recognized that caregiver burden was detrimental to caregiver 
mental health and caused depression rates between 20% and 80%, compared to 13% for 




function of severity of physical and psychological impairment of patient, duration of care, 
and degree of lifestyle changes (Cameron et al., 2016; Pinquart & Sorensen, 2005). 
Depressive symptoms extend beyond well beyond the period of caregiving (Cameron et 
al., 2016). Research indicated that 41% of former caregivers of a spouse dementia 
experienced mild to severe depression three years after termination of caregiving 
responsibility (Denno et al., 2013). A longitudinal study of 280 caregivers found that one 
year after completed caregiving for stroke victims the caregiver depression rate remained 
three times greater than the general population (Cameron et al., 2016). Actual caregiver 
depression rates are moderated by several factors (Pinquart & Sorensen, 2005). 
Subjective well-being, physical health quality and quantity of non-caregiver social roles, 
social roles, socioeconomic status, quality of social relations, health promoting habits, 
personality, and genetic factors moderate caregiver burden and depression. 
Some caregivers with symptoms of depression do not recognize the symptoms in 
themselves, while others have difficulty admitting they feel depressed (Geng et al., 2018). 
Lingering stigma regarding mental illness can make depressive thoughts and feelings 
difficult to express for fear of judgment from others (Geng et al., 2018). Depression is a 
normal pervasive response to caregiver burden. Caring burden is a broad term covering 
ministering to the ill and may be compounded by: (a) illness-related behavioral problems, 
disorientation, and shifts in personality; (b) increased need for supervision and loss of 
spare time; (c) isolation from friends and family: (d) patients inability to appreciate the 
sacrifice involved in caregiving; and I progressive deterioration of the care receiver, 
which reduces the potential for positive outcomes from caregiving sacrifices (Denno et 




Researchers research indicated that depression rates for cancer caregivers increase 
from 20% for newly diagnosed and expand to 50% for terminally ill patients (Sherwood 
et al., 2008). Cancer patient caregivers significantly influence the patient’s disease 
management and palliation, which may adversely affect their mental and physical health 
in the longer run (Geng et al., 2018). Increasing caregiver stress during prolonged 
caregiving produced measurable changes in neurohormonal and inflammatory processes 
that quadruple the risk of depression and may increase morbidity and mortality among 
caregivers (Geng et al., 2018).  
Prolonged patient suffering erodes caregiver resiliency and empathy manifests in 
feelings of despair (Papastavrou et al., 2011). Researchers found that caregiver perception 
of patient suffering contributes to caregiver depression more than patient’s severity of 
illness, behavior, or time in care (Sherwood et al., 2008). Normal deterioration in patient 
health and increases in suffering were associated with caregiver’s depression. 
Compassion derives from a sense of shared suffering coupled with the caregiver’s desire 
to help alleviate it, which may cause feelings of helplessness from the inability to relieve 
patient suffering (Papastavrou et al., 2011). 
Caregiving transitions produce incremental stressors from logistical, financial, 
and emotional sources (Jardim & Pakenham, 2009). As the caregiving setting evolves, so 
do caregiving challenges. Caregivers may relinquish or modify their roles in a manner 
which causes the need to manage other caregivers in the family or professionally. For 
example, movement of a patient into a nursing home evokes feelings of bereavement for 
the loss of a family member’s capability, and because it is the beginning of a new set of 
responsibilities and challenges (MacNeil et al., 2010). Caregivers nursing home visits 




alternative therapies or the need for final arrangements. Poor communication and 
negative interactions with nursing home staff and family members adversely affect 
caregivers (MacNeil et al., 2010). End-stage caregiving often thrusts caregivers into their 
greatest burden with caregivers spending from 100 to 125 hours a week providing 
hospice care.  
Differences in caregiving outcomes often depend on factors well beyond 
caregiver’s capacity and evokes a sense of failure, which contributes to depression and a 
variety of psychiatric and physical maladies (Geng et al., 2018). Research indicated that 
caregivers experience significantly more stress, depression, and lower well-being than 
family-related non-caregivers. Women were significantly more likely to experience 
depression than their male peers. Women are at higher risk because they are more 
conscious of their emotions, tend to be more sympathetic, and are willing to report 
negative feelings (Baider & Bengel, 2010). Also, at high risk for poor health outcomes 
were spousal caregivers because they provide higher intensity hands-on care.  
Past Caregiving Interventions by Category 
Considering the impact of caregiving, researchers have conducted few studies on 
interventions for caregivers. A review of literature within the past decade reveals four 
studies on caregivers of those diagnosed with dementia or Alzheimer’s. Furthermore, the 
research shows past caregiving interventions fall into two categories: (a) reducing amount 
of caregiving and (b) providing information and improving coping skills. All four studies 
fall within the category of providing information and improving coping skills.  
Reducing Amount of Caregiving 
Respite care is temporary substitute relief for caregivers. There are two basic 




or night care for a certain number of hours. In contrast, institutional respite care provides 
care when caregivers need multiple days of relief for holidays, sickness, or when 
caregiving responsibilities interfere with personal demands (Gottlieb & Johnson, 2010). 
The National Alliance for Caregiving (2015) reported that to date no clear evidence 
supports the conclusion that respite care reduces the burden on caregivers or improves 
their mental health. One probable cause of this conclusion is that caregivers typically use 
respite care as a last resort when responsibilities become overwhelming (Gottlieb & 
Johnson, 2010). Additionally, caregivers may see respite as unacceptable because they do 
not want to leave the patient (Gottlieb & Johnson, 2010).  
Providing Information and Improving Coping Skills 
Support groups build understanding between participants surrounding topics, so 
they feel comfortable discussing their problems, successes, or feelings about caregiving. 
They are vehicles to disseminate information, psychosocial support, or education. 
However, Brodaty et al. (2003) found that increased caregiving knowledge is not related 
to social or psychological outcomes. Psychoeducational programs information and 
resources to caregivers regarding the disease process and train them on how to provide 
adequate services.  
Additionally, some psychoeducational interventions include some form of 
psychotherapy. The major disadvantage of this type of intervention is its intensive 
professionally-led nature. Self-reliance and independence are important values to 
caregivers (McMillan et al., 2006). Therefore, many of these intervention programs have 
low participation rates and high attrition rates (McMillan et al., 2006).  
Lopez et al. (2007) examined a stress management program for informal 




individual over the age of 60 who scored a 1 on the Katz Index of Activities of Daily 
Living which measures level of disability, (b) lived at same residence as patient, (c) was 
solely responsible for providing care, and (d) had provided care for patient for at least six 
months. Additionally, participants must not have received any other treatment and have 
shown some evidence of emotional distress as measured by Beck Depression Inventory 
(BDI) or the Hospital Anxiety and Depression Scale. One hundred twenty-three 
caregivers were assessed. Of that number, 14 (11%) did not meet requirements and 18 
(15%) declined to participate. Ninety-one (N = 91) caregivers were used for the sample.  
A multigroup experimental design was used with repeated measures (Lopez et al., 
2007). Participants were randomly grouped into one of three groups: (a) a group that 
received the program through a traditional format, (b) a group that received the program 
with minimal therapist contact, and (c) a control group that was placed on a waiting list 
(Lopez et al., 2007). Likewise, professionals were randomly selected to facilitate each 
treatment. Treatment lasted two months for all groups.  
The traditional group received eight 60-minute weekly sessions. Participants were 
in direct contact with a therapist. They received written exercises and homework between 
sessions. In contrast, the minimal therapist contact group received three 90-minute 
sessions at four-week intervals. Between sessions, caregivers were directed to review 
strategies learned and to go over new ones. The waiting list group did not receive any 
type of treatment or help. Participants were administered both pre- and posttreatment 
with the Katz Index of Activities of Daily Living, Hospital Anxiety and Depression 
Assessment, BDI, Zarit Burden Interview, and the Maladaption Scale (Lopez et al., 




reduction in anxiety and depression compared with caregivers in the minimal therapist 
contact group (Lopez et al., 2007). 
Limitations to the Lopez et al. (2007) study included the absence of a blind 
interview for performing assessments. There might have been possible bias since the 
interviewer knew the participant’s experimental assignment. Another limitation was that 
there was only one measure posttreatment. Therefore, it is unclear if treatment effects 
were short-term or continued. 
Williams et al. (2010) analyzed a video-based coping skills (VCS) training program for 
Alzheimer’s disease and related dementia (ADRD) patients. Their objective was to 
decide if VCS with telephone coaching would reduce psychosocial and biological distress 
in caregivers (Williams et al., 2010). One hundred sixteen (N = 116) ADRD caregivers 
were recruited over a two-year interval through advertisements, support groups, and 
referrals from an Alzheimer’s disease research center in North Carolina (Williams et al., 
2010). Participants were screened for medical problems and those who were non-
caregivers. Then they were randomly placed into two groups: a VCS training group or a 
waiting list control group. 
On day one, participants in the VCS group were given study materials and 
informed of the telephone coaching they would be receiving (Williams et al., 2010). 
Psychological and biological distress markers were immediately tested, and then again at 
seven weeks, three months, and six months. Test measurements used were the CES-D, 
Minnesota Multiphasic Personality Inventory-based Cook–Medley Hostility Scale, 
Perceived Stress Scale, Pittsburgh Sleep Quality Index, Revised Scale for Caregiving 
Self-Efficacy, Spielberger STAI, and the Spielberger State-Trait Anger Inventory 




the fourth visit (Williams et al., 2010). The VCS program consisted of ten 7-minute video 
modules that taught 10 coping skills that dealt directly with caregivers (Williams et al., 
2010). Coping skills taught were (a) changing reactions, (b) evaluating reactions, (c) 
empathizing, (d) listening, I increasing awareness and objectivity, (f) increasing positive 
interactions, (g) problem solving, (h) using assertion, (i) speaking clearly, and (j) saying 
no (Williams et al., 2010). Participants watched a dramatization of a caregiving situation 
that was linked to a specific coping skill. They were required to complete two modules a 
week and all exercises and homework assignments for each module.  
VCS participants also received telephone coaching during the five-week duration 
of the program. Trained telephone coaches called participants weekly to teach that week 
is two coping skills (Williams et al., 2010). Telephone coaches followed a structured 
format including the 10 coping skills and coaching goals. Videos presented caregiving 
scenarios with stress-producing circumstances. They were used to normalize caregiving 
experiences and to enable caregivers to admit or verbalize difficult thoughts or behaviors 
(Williams et al., 2010). The wait list control group were tested at the seven-week, three-
month, and six-month intervals, but received no treatment.  
Williams et al. (2010) researchers found that VCS training with the inclusion of 
telephone coaching was statistically significant in reducing psychosocial and biological 
measures of distress in ADRD caregivers. The main limitation with this study dealt with 
the treatment effects. It was unclear if there was a true effect or response bias because 
participants were paid to complete the study. Also, this study did not show whether 
treatment effects were short-term or continued after treatment. 
O’Connell et al. (2010) evaluated a wellness guide for new older caregivers living 




major university in the United States and was conducted in three stages. In the first stage, 
researchers identified specific needs of caregivers by performing health needs 
assessments. Surveys were mailed to 226 caregivers in a region with an invitation to one 
of two focus groups. In the second stage, researchers collected the data from the focus 
group and developed a wellness guide based on recurring themes using qualitative 
analysis. In the third stage, new caregivers evaluated the wellness guide for its usefulness 
and effectiveness as well as its impact on their health and well-being. O’Connell et al. 
(2010) found that caregiver wellness guides based on caregiver needs assessment is an 
acceptable source for new caregivers. However, a major limitation of the wellness guide 
was whether it continued to have lasting effects on addressing the needs of new 
caregivers.  
Epstein-Lubow et al. (2011) investigated a mindfulness-based stress reduction 
training program for caregivers. Nine (N = 9) female caregivers ages 48 to 73 participated 
in 80 thirty-minute weekly classes geared toward mindfulness-based stress reduction. 
Mindfulness mediation is a type of meditation that allows one to focus their attention on 
bodily sensations and thoughts in the present with a goal to reduce anxiety. Depressive 
symptoms, burdens, perceived stress, anxiety, general health, and mindful attention were 
all measured at pre-intervention, post-intervention, and one-month follow-up.  
Results revealed a decrease in depressive symptoms, perceived stress, and burden 
during the eight-week intervention. Stress and burden continued to reduce after the one-
month follow-up, while depressive symptoms returned to baseline. Mindful attention 
increased for the duration of the study. Additionally, participants reported continued use 
of mindfulness techniques during the one-month follow-up. Limitations to this study 




mindfulness techniques. All these interventions relied upon various forms of behavior 
and psychological modifications with some sort of therapist involvement. One 
intervention does not rely so much on behavior modification as it does on a physiological 
method: cranial electrotherapy stimulation. 
Cranial Electrotherapy Stimulation (CES) 
An alternative anxiety reduction method that has gained attention in literature is 
Cranial Electrotherapy Stimulation. CES uses small electrical impulses that pass across 
the head from electrodes placed on, or near, the ears. Pulse rates can vary from .5 to 100 
HZ in different CES devices, and stimulation intensities can range from 0 – 1.5 mA via 
sinusoidal or modified square waves (Regence Blue Cross Blue Shield, 2018). A review 
of the literature on CES is more challenging due to the variety of names given for the 
same method. Other names include transcranial electrical stimulation, cerebral 
electrostimulation, electrosleep, and alphasleep (Gibson & O’Hair, 1987; Kirsch, 2002; 
Kirsch & Smith, 2004). 
Electromedicine can be traced back in history for thousands of years. The first 
reference of electromedicine occurred in 46 A.D. by the Greek physician Scirbonius 
Largus. He described an application of a black torpedo fish to ease chronic pain  
(Kirsch, 2002). In 1903, Leduc and Rouseau were the first to experiment with low 
currents across the scalp. This was called electrosleep. It would later be introduced to the 
United States in the 1960s (Appel, 1972; Brown, 1975; Gilula & Kirsch, 2005). Since 
then, researchers experiment with multiple versions of electromedicine. It has now 
officially become known as cranial electrotherapy stimulation (Anan’ev et al., 1960; 





Food and Drug Administration (FDA) and CES 
The FDA currently approves Cranial electrotherapy stimulation for anxiety, 
insomnia, and depression (Allevia Health, 2014). In 2012, the FDA stated CES is a class 
II neurological device that applies electrical current to a patient’s head to treat insomnia, 
depression, or anxiety. This type of device was defined as the most stringent regulatory 
category for devices. Class II devices are those for which insufficient information exists 
to assure safety and effectiveness solely through general or special controls” (FDA, para 
9). These devices require pre-market FDA approval which is defined as “the required 
process of scientific review to ensure the safety and effectiveness of Class” (FDA, para 
11). Currently eight companies have FDA approval to sell CES devices (Gilula & Kirsch, 
2005). One such company is Electromedical Products International, Inc (EPI). EPI 
markets their device using the name Alpha-Stim They received FDA approval in May 
1992 (Allevia Health, 2014). The 510(k)-pre-market notification number is K903014 
(Alpha Stim, 2008). To meet FDA approval, the device must meet certain standards 
which include: 
A microprocessor controller box and skin electrodes. The small Controller box is 
software controlled low-intensity output. Current ranges from 0-600 
Microamperes typically set at 0.5 Hz. Additional frequencies at 1.5 and 100Hz are 
available for the physician’s use. The waveform is a bipolar asymmetric rectangle 
shape with a 50% duty cycle, 0 net current. Current is applied using silver 
electrodes with self-adhesive pads applied to the ear lobes (Allevia Health, 2014).  
Simply stated, the CES unit is a small device that utilizes software to produce low 




How CES Works 
It is not clear how CES works. However, several researchers have attempted to 
answer the question (Giordano, 2014). Since the initial studies, researchers proposed 
several theories. One such theory is that micro current waveforms projected by the CES 
unit stimulate and change neurological nerve cells that in turn fine-tune the brain. It was 
hypothesized that the raphe-nuclei is stimulated when ear clip electrodes are clipped to 
the earlobes near the mastoid bone (Giordano, 2014). Giordano (2014) stated:  
This neurological fine-tuning is called modulation, and occurs either as a result of, 
or together with the production of a certain type of electrical activity pattern in the 
brain known as an alpha state which can be measured on brain wave recordings 
(called electroencephalograms, abbreviated EEG). Such alpha rhythms are 
accompanied by feelings of calmness, relaxation and increased mental focus. The 
neurological mechanisms that are occurring during the alpha state appear to 
decrease stress effects, reduce agitation, and stabilize mood, and regulate both 
sensations and perceptions of particular types of pain. (p. 1) 
Gilula and Kirsch (2005) discussed the CES effect on the limbic system, reticular 
activating system (RAS), the hypothalamus, and the thalamus on the nervous system. 
Toriyama (1975) suggested CES works through the parasympathetic nervous system. 
Smith (2002) stated that “neurotransmitters that are out of homeostasis due to some prior, 
reasonably prolonged stress reaction, whether it be psychological or physical such as 
drug abuse, will come back into homeostasis and any concomitant anxiety, depression or 
sleep problems will subside” (p. 5). Childs and Price (2007) stated that anti-aggressive 
effects of CES generate due to an increase of alpha waves created. It was also reported 





Currently, there are more than 175 published studies for CES reporting significant 
results with most of them reporting a positive reduction in anxiety and/or stress. 
Approximately 75 were designed to measure anxiety reduction using CES. Some of those 
studies are Briones & Rosenthal, 1973; Feighner, Brown, & Oliver, 1973; Frankel, 
Buchbinder, & Snyder, 1973; Gibson & O’Hair, 1987; Gilula & Kirsch, 2005; Hearst, 
Cloninger, Crews, & Cadoret, 1974; Heffernan, 1996; Jemelka, 1975; Kirsch & Nichols, 
2013; Krupitsky et al., 1991; Passini, Watson, & Herder, 1976; Phillip, Demotes-
Mainard, Bourgeois, & Vincent, 1991; Rosenthal, 1972; Strentzsch, 2009; Taylor, Lee, & 
Katims, 1991;Von Richthifen & Mellor, 1980; Voris, 1995; Winick, 1999). 
Thirty-five studies reported using a double-blind technique. In these studies, 
participants were divided into two groups: One group received CES and the other 
received a sham treatment. Eleven of these studies investigated anxiety (Briones & 
Rosenthal, 1973; Feighner et al., 1973; Hearst et al., 1974; Heffernan, 1996; Jemelka, 
1975; Passini et al., 1976; Phillip et al., 1991; Rosenthal, 1972; Von Richthifen & Mellor, 
1980; Voris, 1995; Winick, 1999). Additionally, three studies used a placebo control 
designed to rule out placebo effects during the administration of CES as opposed to sham 
CES. Neither found placebo effects (Lichtbroun, Raicer, & Smith, 2001; Strentzsch, 
2009; Taylor et al., 1991).  
Anxiety research that uses CES dates from 1968 to the present. Most of these 
studies were conducted in the 1970s (Kirsch, 2002). Negative outcome studies were all 
between 1965 and 1980 (Kirsch, 2002). No Alpha-Stim has ever received a negative 




four measured anxiety (Moore, Mellor, Standage, & Strong, 1975; Passini et al., 1976; 
Tomsovic & Edwards, 1973; Von Richthifen & Mellor, 1980).  
Gilula and Kirsch (2005) examined the effectiveness of CES as opposed to 
medication in treating depression. The goal of the study was to determine if evidence 
supported CES as an alternative to pharmaceuticals. Researchers found an equal benefit 
over placebo for CES opposed to medication. In contrast to pharmaceuticals and its 
various side effects, CES has no reported serious side effects (Gilula & Kirsch, 2005). 
Numerous methods have been used to measure effectiveness of CES, including 
electrocardiogram (EKG), electroencephalogram (EEG), electromyogram (EMG), skin 
conductance, blood pressure, pulse, respiration, heart rate, body chemistry, peripheral 
tension, BDI (Beck et al., 1988), Hamilton Anxiety Scale, Hamilton Depression Scale, 
Global Evaluations, Minnesota Multiphasic Personality Inventory (MMPI), State/Trait 
Anxiety Inventory, Taylor Manifest Anxiety Scale, and the Zung Depression Scale 
(Kirsch, 2002). Few studies have used neurotransmitter levels as an outcome measure 
(Frankel et al., 1973; Krupitsky et al., 1991; Scherder et al., 2003; Shealy, Cady, Culver-
Veehoff, Cox, & Liss, 1998; Shealy, Cady, Wilkie, Cox, & Clossen, 1989).  
Summary 
This chapter presented cranial electrotherapy stimulation as an alternative method 
of reducing anxiety and depression in caregivers. The review of literature indicates that 
multiple research studies of caregiving interventions have been conducted. However, 
many of these studies failed to show whether treatment effects were short-term or had 
long lasting effects beyond treatment. The history of cranial electrotherapy stimulation 
was briefly outlined, and numerous detailed studies supported the FDA-approved device 




Chapter 3  
Methodology 
Currently, no other research study has investigated interventions for depression 
and anxiety symptom reduction for caregivers outside the interventions of reducing the 
amount of caregiving or providing information and coping skills. The purpose of this 
experimental pretest post-test two-group double-blind design study was to examine the 
efficacy of cranial electrotherapy stimulation (CES) to reduce anxiety and depressive 
symptoms for a sample of 35 caregivers.  
Research Design 
This study uses an experimental pretest post-test two-group double-blind design. 
Researchers may unintentionally change research outcomes in a variety of ways. They 
may offer a smile (which offers a sense of encouragement) for a right answer or offer a 
frown for a wrong answer (Krathwohl, 1998). This design ensures that both the 
administrator and those receiving treatment are blind to which group receives the 
different treatments (Krathwohl, 1998). The sham CES treatment group consists of the 
participants who are given treatment that was meant to not have an effect, and the active 
CES treatment group consisted of participants who were given treatment that is meant to 
have an effect. This study uses an experimental pretest post-test 2-group double-blind 
design. This design ensures that both the administrator and those receiving treatment are 
blind to which group receives what (Krathwohl, 1998). Electromedical Products 
International, Inc. (EPI) provided the CES devices to the researcher. Before delivery to 
the researcher, EPI coded the devices as active or sham. Neither the researcher nor the 




Assumptions and rationale for design. This study is designed to respond to 
limitations represented in the current body of literature regarding interventions for 
anxiety and depressive symptoms in caregivers. CES is an electronic device approved by 
the U.S. Food and Drug Administration (2018) for reducing symptoms if anxiety, 
depression, and insomnia. Current literature has identified a primary limitation of a lack 
of double-blinding experimentation necessary to eliminate researcher bias. To ensure 
double-blindness, EPI will code all CES devices as either active or sham before sending 
the devices to the researcher. After completion of the three-week treatment protocol and 
final data gathering, EPI will inform the researcher which CES devices are active and 
which are sham.  
The researcher selected this population due to multiple studies in the body of 
literature that found caregivers have high risk of adverse health, psychological, and 
financial effects because of increased anxiety and depressive symptoms related to their 
caregiver role (Ashley et al., 2011; Harris et al., 2011; King et al., 2010; MacNeil et al., 
2010; Martin et al., 2011; Pioli, 2010; Turner et al., 2010). Traditional treatment methods 
for reducing anxiety and depressive symptoms for caregivers include either reducing 
caregiving or providing information and coping skills (NAC, 2015). Because there has 
been high dropout rates in studies using these traditional treatment methods (McMillan et 
al., 2006), the researcher believes that this population would benefit most from an 
alternative treatment method that requires little, if any, modification of the caregiving 
routine or additional time taken away from caregiving and other usual activities. 
 Participants. To be eligible, participants must be living in the Houston area, be at 
least 18 years old, and be currently providing care to an individual who is disabled, 




Sampling. This study used a sample size of 40 caregivers in the Houston area. The 
researcher recruited participants from caregiving agencies and organizations in the 
Houston area by sending out emailed invitations to invite participants to the study. 
Risks. There were both physical and psychological risks to participants. Physical 
reactions to the skin, dizziness, and nausea may occur when using the CES device. 
Psychological risk may include re-emergence of negative feelings when taking the 
Beck’s Depression Index (BDI) and State-Trait Anxiety Inventory (STAI).  
Confidentiality and Informed Consent. All data collected was confidential 
including test results, demographic questionnaires, and tracking sheets. The informed 
consent is the only place the participants’ names will appear. Names will not appear on 
the STAI, the BDI, or demographic questionnaire. All final data were used only for 
publication and research purposes. 
Costs. There were no costs associated with this study for participants. However, 
participants will need to devote time to complete the 3-week CES protocol and track their 
use of the CES device each day on the tracking sheet (Appendix A). 
Role of the Researcher. The researcher’s role is to find participants, ensure 
integrity of the study, answer questions of the participants, collect data, and interpret 
findings.  
Data Collection Procedures  
Prior to data collection. Permission for the study was obtained from the St. 
Mary’s University Institutional Review Board (Appendix B). An invitation (Appendix 
C)) and common asked question brochure were then sent out to area caregiver agencies to 
invite caregivers to be a part of the study in order to reach a sample size of 40 




care provider prior to participating in the study. If yes, their data was not used in the 
study. All participants were given a participation letter, informed consent form 
(Appendix D), common questions brochure, demographic questionnaire (Appendix E), 
State-Trait Anxiety Inventory (Appendix F), and Beck’s Depression Inventory to 
complete. If participants receive a score of 20 or above on the State-Trait Anxiety 
Inventory or Beck’s Depression Inventory they were given a referral list of mental health 
care providers. The consent form and information sheet were kept separate from the data 
containing each participant’s name, contact information, and assigned number identifying 
each participant. The assigned number will also be placed on participants pre and post 
surveys. The surveys were kept separate from the consents and information sheets so that 
the surveys remain unidentifiable. 
Participants were asked to use their CES device each day for 60 minutes for three 
weeks. The researcher will teach participants how to use the CES device when devices 
are delivered to each participant. See training protocol (Appendix G). Upon completion 
of the 3-week CES protocol, participants will repeat the test measurements taken at the 
start of the study. Participants were asked if they received any treatment from a mental 
health care provider since starting their participation in the study. If yes, their data will 
not be used in the study. Participants with significant missing data were removed from 
data analysis. Data collection will continue until participant numbers are met with 
completed data. After a participant has completed the study and returned the device, the 
researcher will cut out the participant’s name and contact information from the master list 
and will shred this information.  
The STAI is a 40-item scale used to assess two types of anxiety: trait anxiety and 




situations as threatening. State anxiety is how intensely one will respond to a perceived 
threatening situation (Spielberger, 1983). Under psychological stress, test-retest 
reliability ratings for the STAI assessment tool vary between .89 and .94. However, there 
is a larger variance of .16 and .94 in the populations. Comparing both forms to all 
populations creates a .65 correlation between all responses (Spielberger, 1983).  
The BDI is a 21-item, self-report inventory that measures attitudes and the 
symptoms of depression (Beck et al., 1988). Developed in several forms, including 
computerized administration, it can be completed in approximately 10 minutes. A fifth-
grade reading level is required to understand the questions (Beck et al., 1988). Internal 
validity ranges from .73 to .92 with a mean of .86. It demonstrates high internal validity, 
with alpha coefficients of .86 and .81 for psychiatric and non-psychiatric populations 
(Beck et al., 1988).                                                                                                                                                                                         
Data Analysis Procedures  
The data collected from the pre- and posttest results of the STAI scores, BDI 
scores, and demographic data sheet were entered in a dataset using SPSS. Descriptive 
statistics and frequency tables were executed using information gathered from the 
demographic questionnaire. After completing descriptive analysis, inter-item reliability 
analysis were conducted on the STAI and BDI measures to determine reliability in the 
sample. After reliability analysis, a repeated measure multivariate analysis of variance 
(MANOVA) were conducted to address variance between pre- and posttest scores for the 
STAI and Beck’s Depression Inventory scores. Results will then be examined for the 




Security and Confidentiality of Data  
This study will require paper records of the informed consent form, demographic 
questionnaire, State-Trait Anxiety Inventory, Beck Depression Inventory, and the 
tracking sheet. The informed consent were kept separate from all other data in order to 
ensure confidentiality. They were sent to the Sponsored Programs Academic Research 
and Compliance office at St. Mary’s University where they were stored and disposed of 
according to federal regulations. All other hard copy data were stored in a locked cabinet 
in a locked room in the researcher’s house and will have codes associated with the 
participants data forms. All electronic data forms were password protected. All data were 
kept for five years and then shredded by the researcher. No follow up treatment was 
















Chapter 4  
Data Analysis  
The purpose of this experimental pretest post-test two-group double-blind design 
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce 
anxiety and depressive symptoms for a sample of 35 caregivers. The research design 
required that neither the administrator or those receiving treatment knew which CES 
device was active and which were sham. To ensure double-blindness, Electromedical 
Products International, Inc. (EPI) coded all CES devices as either active or sham prior to 
sending devices to the researcher. After completion of the three-week treatment protocol 
and final data gathering, the researcher opened the sealed envelope from EPI that 
informed the researcher which CES devices were active and sham based on serial 
numbers. The researcher was then able to identify the participants who were in the 
treatment group and those who were in the control group. 
Participants had been trained on how to use the CES device and instructed to use 
the CES device each day for 60 minutes for three consecutive weeks. Prior to the first 
CES session, each participant completed both the Beck Depression Index (BDI) and 
State-Trait Anxiety Inventory (STAI) to create a bassline. Upon completion of the there-
week CES protocol, participants again completed the BDI and STAI. This chapter 
includes a discussion of the data analysis results. Descriptive statistics were employed to 
characterize the study sample demographically and summarize study variable data for the 
treatment and control groups.  
Data Collection  
The study sample included 35 caregivers willing to follow the CES protocol for a 




caregivers were randomly assigned CES devices. All participants completed the CES 
protocol, BDI, and STAI. Two participants chose not to provide certain demographic data 
and were included in the study. Otherwise, no other data issues emerged.  
Findings  
Tables 3 through 11 summarize demographic data distributions for control and 
treatment groups based on age, caregiver status, caregiver hours, caregiver experience, 
ethnicity, gender, income, marital status, and, number of individuals cared for, and 
patient’s illnesses. As shown in Table 3, for gender distribution, of the 35 participating 
caregivers, the sample included 24(68%) females, 10(29%) males, and 1(3%) who 
provided no gender data. Control and distribution groups included similar distributions by 
gender with approximately two-thirds female.  
Table 3 
Gender Distribution by Group 
Group                    Gender   n % 
Control  Female 12                         70.6
Male    4   23.5 
Unknown   1     5.9 
Total 17 100.0 
Treatment  Female 12   66.7 
Male   6   33.3 
Unknown   0      0.0 
Total 18 100.0 
 
As shown in Table 4, both groups contained a wide range of ages, from 18 to 30 
age group through the 60+ age group. The age distributions between the control group 







Age Distribution by Group  
Group                    Age  n  % 
Control  18 to 30 2   11.8 
31 to 40 4   23.5 
41 to 50 7     41.2 
51 to 60 2   11.8 
60+ 2   11.8 
Total       17 100.0 
Treatment  18 to 30 2   11.1 
31 to 40 3   16.7 
41 to 50 9   50.0 
51 to 60 0     0.0 
60+ 4   22.2 
Total       18 100.0 
 
Table 5 details caregiver status by group. Caregiver status distributions between 
the control group and treatment group were similar. Between 82.4% and 94.4% were 
informal caregivers.  
Table 5 
Caregiver Status Distribution by Group 
Group                   Caregiver Status          n                            %              
Control  Formal   3   17.6 
Informal 14   82.4 
Total 17 100.0 
Treatment  Formal   1     5.6 
Informal 17   94.4 
Total 18 100.0 
As shown in Table 6, the ethnicity distribution contained various ethnicities. The 
ethnicity distributions between control and treatment groups were similar. Black and 






Ethnicity Distribution by Group 
Group                              Ethnicity   n      % 
Control  Asian   1     5.9 
Black    9    52.9 
Latino   2    11.8 
P. Islander   1     5.9 
White   2    11.8 
Unknown   1     5.9 






  0 
 
       0 
Black 12    66.7 
Latino   4   22.2 
P. Islander   0        0 
White   1     5.6 
 Unknown   1     5.6 
                    Total 18 100.0 
As shown in Table 7, the marital status distribution between the control and 
treatment groups were similar. In the control group, 35.5% of the participants were 






Marital Status Distribution by Group 
Group                    Marital status n                       % 
Control  Single 8 47.1 
Cohabitating 3 17.6 
Married 3 17.6 
Divorced 1 5.9 
Widowed 1 5.9 
     Unknown 1 5.9 
          Total            17 100.0 
Treatment  Single 7 38.9 
Cohabitating 2 11.1 
Married 6 33.3 
Divorced 2 11.1 
Widowed 0 0.0 
Unknown 1 5.6 
          Total            18 100.0 
As shown in Table 8, in the control group 12 (70.0%) participants reported 
providing more than 11 hours of caregiving per week, while in the treatment group only 8 
(50%) participants reported providing more than 11 hours of caregiving per week. The 
number of caregiver hours was somewhat greater for the control group. The overall 






Caregiver Hours Distribution by Group 
Group                    Caregiver hours n            % 
Control  1 to 10 hours 5 29.4 
11 to 20 hours 5 29.4 
31 to 40 hours 4 23.5 
Greater than 40 hours 3 17.6 
Unknown                  0 0.0 
Total 17 100.0 
Treatment  1 to 10 hours 9 50.0 
11 to 20 hours 4 22.2 
31 to 40 hours 3 16.7 
Greater than 40 hours 1 5.6 
 Unknown 1 5.6 
           Total 18 100.0 
As shown in Table 9, the treatment group was more varied in the amount of 
caregiving years. The treatment group had more relatively new caregivers and a greater 
number of longer experienced caregivers than the control group. Most of the control 
group had between 2 and 5 years of experience.   
Table 9 
Years as Caregiver Distribution by Group 
Group  Years as caregiver          n     %  
Control  Less than 2 years  5   29.4 
2 to 5 years 11   64.7 
 Greater than 5 years   0     0.0 
 Unknown  1      5.9 
          Total 17 100.0 
     
Treatment  Less than 2 years 10   55.6 
2 to 5 years  3   16.7 
Greater than 5 years 4   22.2 
 Unknown 1      5.6 





As shown in Table 10, both the treatment group and control had similar numbers 
of patients for whom they provided care. The control group had three participants who 
provided care to three or more patients. The treatment group had more participants who 
provided care to two patients, but this group had no participants who provided care to 
three or more patients.  
Table 10 
Number Cared for Distribution by Group 
Group         Number cared for               n % 
Control  1 13 76.5 
2 1 5.9 
3 2 11.8 
Greater than 3 1 5.9 
Total 17 100.0 
Treatment  1 14 77.8 
2 4 22.2 
3 0 0.0 
Greater than 3 0 0.0 
Total 18 100.0 
 
As shown in Table 11, the control group income primary distribution was as 
follows: 13 (76.6%) reported income between $31,000 and $69,000, while the treatment 
group had 9 (50%) report income between $31,000 and $79,000. The treatment group 





Income Distribution by Group 
Group                    Income         n                           %               
 Control  Less than 30K 1 5.9 
31k to 39k 4 23.5 
40k to 49k 2 11.8 
50k to 59k 4 23.5 
60k to 69k 3 17.6 
70k to 79k 1 5.9 
80k to 89k 1 5.9 
90k to 99k 1 5.9 
 Total 17 100.0 
Treatment  Less than 30K 3 16.7 
31k to 39k 0 0.0 
40k to 49k 2 11.1 
 50k to 59k 7 38.9 
60k to 69k 1 5.6 
 70k to 79k 2 11.1 
80k to 89k 3 16.7 
90k to 99k 0 0.0 
 Total 18 100.0 
 
Statistical Assumptions   
Paired sample t-test were conducted to assess hypotheses 1 and 2, and Pearson 
correlation was employed to test hypothesis 3. The assumption is that pre and post BDI 
and STAI data for both the control and treatment groups were approximately normally 
distributed, and a scatterplot reveals a linear relationship. Parametric statistical methods 
such as Pearson correlation and paired sample t-tests, assume that dependent variable 
data (BDI score and STAI score) are approximately normally distributed and linear. 
As shown in Table 12, Shapiro-Wilk’s was conducted on the eight subsets of 
dependent data depicted to test for normality and linearity (Leedy, Ormrod, & Johnson, 




treatment and control groups met the assumptions for linearity. None of the eight 
Shapiro-Wilk’s tests for normality were significant at p < .05, meaning that all eight 
subsets of dependent variables depicted in Table 12 met the assumption for normality.  
Table 12 
Test of Normality 
   Shapiro-Wilk’s  Statistic df Significance 
Control  Pre-BDI .923 17 .164 
Pre-STAI .961 17 .648 
Post-BDI .803 17 .119 
Post-STAI .814 17 .112 
Treatment  Pre-BDI .932 18 .208 
Pre-STAI .938 18 .263 
Post-BDI .946 18 .360 
Post-STAI .946 18 .372 
 
Hypothesis Tests  
RQ1: Did caregivers receiving active CES treatments experience a greater 
reduction of anxiety symptoms than the caregiver control group? 
Ho1: Participants who received active CES treatments did not experience 
significantly greater anxiety reduction, as measured by STAI scores, as compared 
to the control group.  
Ha1: Participants who received active CES treatments experienced significantly 
greater anxiety reduction, as measured by STAI scores, as compared to the control 
group.  
Table 13 reports pre and post STAI score mean, standard deviation, and standard 
error for the control and treatment groups. A paired-samples t-test was conducted to 
compare control group STAI score before and after CES treatment. For the control group, 




(M = 31.65, SD = 5.65) treatment was statistically significant; t(16) = 3.119, p = .001. A 
paired-samples t-test was conducted to compare treatment group STAI score before and 
after CES treatment. For the treatment group, the 12.05 mean difference in STAI scores 
between pre (M = 43.61, SD = 10.99) and post (M = 31.56, SD = 4.11) treatment was 
statistically significant; t(17) = 4.189, p = .001. However, there was no significant 
difference in pre and post STAI score improvement (Mean difference = 1.52) between the 
treatment group and the control group t(34) = .345, p = .732. Therefore, the null 
hypothesis was accepted, there was no difference in anxiety symptom reduction between 
the control group and the treatment group.  
Table 13 
STAI Scores by Group  
Group  Dependent Variable Mean Mean Diff. n SD Std. Error 
Control 
Treatment 
 Pre-STAI 42.18 -- 17 13.28 3.22 
Post-STAI 31.65 10.53 17   5.65 1.37 
 Pre-STAI 43.61 -- 18 10.99 2.59 
Post-STAI 31.56 12.05 18   4.11 0.97 
 
RQ2: Did participants receiving active CES treatments experienced a greater 
reduction of depressive symptoms, as measured by BDI scores, compared to the control 
group?  
Ho2: Participants who received active CES treatments did not experience greater 
depressive symptom reduction, as measured by BDI scores, as compared to the 
control group.  
Ha2: Participants who received active CES treatments experienced significantly 
greater depressive symptom reduction, as measured by BDI scores, as compared 




Table 14 reports pre and post BDI score mean, standard deviation, and standard 
error for the control and treatment groups. A paired-samples t-test was conducted to 
compare control group BDI score before and after CES treatment. For the control group, 
the 9.12 mean difference in BDI scores between pre (M = 18.41, SD = 13.12) and post (M 
= 9.29, SD = 7.29) treatment was statistically significant; t(16) = 4.139, p = .001. A 
paired-samples t-test was conducted to compare treatment group BDI score before and 
after CES treatment. For the treatment group, the 10.39 mean difference in BDI scores 
between pre (M = 16.11, SD = 11.31) and post (M = 5.72, SD = 3.89) treatment was 
statistically significant; t(17) = 4.189, p = .001. However, there was no significant 
difference in pre and post BDI score improvement (Mean difference = 1.57) between the 
treatment group and the control group t(34) = .415, p = .675. Therefore, the null 
hypothesis was accepted, there was no difference in depressive symptom reduction 
between the control group and treatment group.  
Table 14 
BDI Statistics by Sample  
 
 
RQ3: What is the relationship between anxiety symptoms, as measured by the 
STAI, and depressive symptoms, as measured by the BDI, in caregivers? 
Ho3: There is no significant relationship between STAI scores and BDI 




  n  SD Std. Error 
Control  Pre-BDI  18.41 -- 17 13.12 3.18 
Post-BDI    9.29   9.12  17   7.29 1.76 
Treatment  Pre-BDI  16.11 --  18 11.31 2.66 




Ha3: There is a significant relationship between STAI scores and BDI 
scores for caregivers.  
Pearson correlation statistics were conducted to address Research Question 3. 
Table 15 depicts correlations and significance for the pre BDI – STAI relationship and 
the post BDI – STAI relationship. The pre-CES treatment BDI- STAI relationship was 
strong and statistically significant (r = 0.575, p < .000). The pre-CES treatment BDI- 
STAI relationship was strong and statistically significant (r = 0.668, p < .000). Therefore, 
the null hypothesis is rejected, there was a strong significant correlation between BDI 
score and STAI score for the overall sample.  
Table 15 
BDI - STAI Correlations 
 Post-BDI Pre-STAI 
Post-STAI Pearson Correlation    .575** -- 
Sig. (2-tailed) .000 -- 
Pre-BDI Pearson Correlation --    .668** 













Chapter 5  
Discussions, Conclusions, and Recommendations 
The purpose of this experimental pretest post-test two-group double-blind design 
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce 
anxiety and depressive symptoms for a sample of 35 caregivers. To study this 
phenomenon, the researcher drew data from among 35 caregivers to determine whether 
CES treatment helped them experience a decrease in anxiety and depressive. The 
researcher hypothesized that participants who received treatment would experience 
reductions in anxiety symptoms (as gauged by STAI scores) and depressive symptoms 
(as gauged by BDI scores).  
The methodology chosen used an experimental pretest post-test two-group 
double-blind design to ensure that both the administrator of the test and those receiving 
the treatment were blind to which group received the genuine treatment and which 
received the sham treatment. Data was collected from CES devices used by participants 
and analyzed for both pre- and post-test results on STAI and BDI scores. The findings of 
the study, reported in Chapter IV, are discussed in the following sections.  
Participant Demographics  
A non-random convenience sampling technique was employed to recruit and 
select participants. More than 80% of all 35 participants were informal caregivers, and 
there was no publicly available demographic information regarding the general 
population of informal caregivers in Houston. Thus, the researcher was unable to 




Interpretation of the Findings  
Three research questions were developed to guide the current study. The first 
research question for the study was as follows: 
RQ1: Did caregivers receiving active CES treatments experience a greater 
reduction of anxiety symptoms than the caregiver control group? 
Findings indicated that there was no statistically significant difference in anxiety 
symptom reduction between CES treatment and control groups, even though both groups 
reported experiencing significantly lower anxiety symptoms. As such, CES treatment did 
not appear significantly more effective in reducing anxiety symptoms than a placebo. The 
findings were not consistent with proposals regarding CES, which researchers indicated 
may be useful for addressing a variety of conditions through the stimulation of raphe-
nuclei (Giordano, 2014). Researchers previously broadly indicated that the use of CES 
could influence multiple parts of the brain and nervous system, such as the hypothalamus, 
thalamus, and totality of the nervous system (Gilula & Kirsch, 2005).  
Smith (2002) also indicated that neurotransmitters may fall out of homeostasis 
because of prolonged stress reactions in response to both physical and psychological 
stimuli. The use of CES was noted as an effective means of reducing anxiety in numerous 
studies (Briones & Rosenthal, 1973; Feighner et al., 1973; Frankel et al., 1973; Gibson & 
O'Hair, 1987; Gilula & Kirsch, 2005; Hearst et al., 1974; Heffernan, 1996; Jemelka, 
1975; Kirsch & Nichols, 2013; Krupitsky et al., 1991; Passini et al., 1976; Phillip et al., 
1991; Rosenthal, 1972; Strentzsch, 2009; Taylor et al., 1991; Von Richthifen & Mellor, 
1980; Voris, 1995; Winick, 1999). As such, it was anticipated from the existing literature 




Despite all the evidence suggesting that CES should be useful in treating anxiety, 
the current study did not seem to yield similar results. Consequently, that places the 
current study as the outlier regarding the rest of the literature. The findings suggest there 
may be specific conditions among caregivers that influence their anxiety that the use of 
CES does not address.  
RQ2: Did participants receiving active CES treatments experience a greater 
reduction of depressive symptoms, as measured by BDI scores, compared to the control 
group?  
Findings indicated that there was no statistically significant difference in 
depressive symptom reduction between CES treatment and control groups, even though 
both groups reported experiencing significantly lower depressive symptoms. As such, 
CES treatment did not appear significantly more effective in reducing depressive 
symptoms than a placebo. This finding was inconsistent with the expectations generated 
from the literature. Past research suggested that CES should help address negative mental 
health conditions. However, this was not found in the current study. Once again, this 
suggests that caregivers may have unique situations that lead to depressive symptoms, 
meaning that alternatives to addressing those symptoms may be necessary rather than 
employing CES. Given the above findings, the research produced within the current study 
contradicted previous indications in the literature that CES may help. 
RQ3: What is the relationship between anxiety symptoms, as measured by the 
STAI, and depressive symptoms, as measured by the BDI, in caregivers? 
After testing to determine the relationship between anxiety symptoms and 
depressive symptoms in caregivers, the researcher found that there was a strong 




BDI scores. Previous indications from the National Alliance for Caregiving (2015) 
indicated that caregiving work may lead to both anxiety and depression, therefore, the 
findings that both occurred among caregivers was consistent with the previous literature. 
However, there was little else identified in the literature suggesting that the two may 
occur in tandem. As such, the current findings were relatively novel when contextualized 
within the larger literature and added a unique contribution to the existing research.   
Limitations of Study  
The choice of various research methodologies can have limitations (Krathwohl, 
2009). It is up to researchers to recognize and determine if the benefits of the chosen 
study design outweigh the cost of the chosen approach (Krathwohl, 2009). Within the 
context of the current study, the choice of research design was deemed of greater benefit 
than the associated costs. Regardless, the identified limitations may have reduced the 
efficacy of the study, though steps were taken to address these limitations to the greatest 
degree possible.  
One limitation recognized was the lack of a true randomization process for 
sampling the identified population. For this study, participants were recruited from the 
Houston area. However, owing to variation in caregiving work schedules, there was a 
lack of available caregivers willing to participate at any given time. As such, sampling 
could not be randomized. A second limitation to the study was the nature of the topic. 
The topic of CES may have seemed uncomfortable to some caregivers, who may not 
have felt inclined to participate (biasing the sample), or who answered without full 
honesty during the study.  
The small size sample due to the practical limitations limited generalizability of 




representative of caregivers in the Houston area. The following practical limitations limit 
findings. First, participant sessions were not monitored, so it was possible that some 
participants did not use the devices as required for the study. Second, it is possible that 
caregiving could have changed during the use of the device or that the caregivers 
experience stressors during the study affecting their posttest scores. Third, participants 
could have guessed that they had been given active or sham devices, which affected their 
posttest scores. Fourth, although the samples were somewhat similar, the control sample 
reported spending more hours giving care and more years of experience giving care than 
the treatment group. It is possible that these differences affected the outcome. Fifth, the 
treatment protocol was for 21 days with immediate posttest at the end without follow-up. 
it was not known if additional change could have occurred with longer term CES usage.  
Recommendations  
The fact that both groups improved in both symptoms suggests that caregivers can 
reduce their anxiety and depressive symptoms with minimal intervention. Caregivers may 
just need to believe they are doing something or feel hope that improvement can occur. 
This would imply that any intervention could result in improvement. A few practical 
recommendations can be made from the current study. In short, it did not seem that CES 
helped to address either anxiety or depression in caregivers significantly more than the 
placebo. Given that as the case, no recommendation could be made suggesting that CES 
be applied among caregivers as a means of addressing these symptoms. Considering the 
lack of effectiveness of CES, such devices should not be employed among caregivers for 
addressing issues of anxiety and depression. As such, the most practical recommendation 




caregivers to seek out alternative methods for addressing both anxiety and depression 
among these individuals. 
Regarding research recommendations, it is clear from the findings that the current 
research conflicted with the vast amount of literature regarding CES use for anxiety and 
depressive symptom reduction. The body of literature indicated that CES should have had 
some statistically significant greater impact on these symptoms than a placebo. Yet, the 
current research did not reach this objective. Considering that the findings of the current 
research were in such contrast to the previous findings, further investigation of this 
population is necessary. First, there is the issue of the small sample drawn for this 
research. The sample size may have disproportionately impacted the current study 
findings. As such, expanding the sample to increase the power may yield different results 
from those reached in the current version of the study. One recommendation for future 
research is to include a more representative sample of the population in the higher-
powered sample. 
A second recommendation for future research would be to examine the nature of 
the sample. Research could explore whether there are specific characteristics that 
distinguish the jobs of caregivers from roles that others fill in other careers. If so, this 
may help to explain why the use of CES did not provide greater help in addressing the 
anxiety and depressive symptoms experienced among this sample. A qualitative 
investigation of these caregivers could yield data on unique phenomenon common to 
their roles that may make caregivers more resistant to positive outcomes from CES 
treatment.  
A third recommendation for future research would be to analyze the nature of the 




necessitate replication to determine whether the same results can be achieved. If not, then 
it may indicate a fundamental flaw in the design of the research that would need to be 
addressed before the research can be repeated. Considering the outlier status of the 
findings, it brings to question whether there may have been a design flaw that could have 
affected the outcomes. As such, replication attempts may help clarify whether the current 
study’s findings typify the target population. 
Another recommendation would be to replicate the study with low cost treatments 
that would not be time consuming for caregivers. Considering that both CES and a 
placebo yielded a significant reduction in anxiety and depressive symptoms, it is possible 
that low cost treatments that do not require great time commitments from caregivers 
would be effective. For example, training caregivers in breathing exercises and 
mindfulness, which could be employed during caregiving activities, could assist 
caregivers in reducing their anxiety and depressive symptoms. One of the reasons for the 
decision to study CES with this population is because caregivers often do not have the 
time to devote to attend counseling groups or to participate in self-care activities that take 
them away from their caregiving responsibilities. If a low-cost treatment that does not 
take the caregivers’ time were identified, this could help many caregivers. 
Implications  
Given that CES failed to impact anxiety and depression in the sample drawn for 
this study, the implication is that CES may not be as successful at addressing these issues 
as the vast amount of prior literature suggests. If this is the case, then it may necessitate 
revisiting old literature, and reviewing the studies, to assess the quality of each study’s 
design to determine whether the findings were valid. A second implication of the study 




sample. If anxiety and depression occur together, then it implies they may have similar 
roots and develop along similar mental pathways. In this regard, the implication is that 
caregivers may have both anxiety and depressive symptoms manifest as a response to the 
duties the individuals must complete and the emotional experiences that caregivers have 
as they care for their patients. 
Conclusion  
The purpose of this experimental pretest post-test two-group double-blind design 
study was to examine the efficacy of cranial electrotherapy stimulation (CES) to reduce 
anxiety and depressive symptoms for a sample of 35 caregivers. To complete this study, 
35 participants were recruited into a pretest post-test two-group double-blind study. The 
underlying hypothesis was that participants who received treatment would experience 
reductions in anxiety and depressive symptoms.  
Following an analysis of the data, the researcher’s hypotheses that CES would 
help reduce symptoms of anxiety and depression were not supported. This contextualized 
the current study as an outlier against the larger body of literature, which suggested that 
CES should have a greater positive impact on symptoms than a placebo. The lack of 
greater improvement through CES suggested that the current study may have included 
unique features within the research design that produced significantly different findings 
from those previously found in the literature. 
Based on the current research, CES cannot be recommended as a treatment for 
anxiety and depressive symptoms among caregivers. The study indicated that anxiety and 
depressive symptoms both occurred among this population and that both the treatment 
and control groups experienced lowered anxiety and depressive symptoms. As such, there 




varying ways to treat anxiety and depressive symptoms in this population. Because both 
the treatment and the placebo were effective in lowering anxiety and depressive 
symptoms, counselors and other mental health professionals should keep an open mind to 
creatively treating caregivers. It is possible that caregivers could lower their anxiety and 
depressive symptoms just by participating in treatments that they believe will result in 
change. Thus, future research should investigate low cost treatments that do not require a 
lengthy time commitment from caregivers to address these symptoms rather than relying 
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Dear Mr. Jefferson: 
 
The IRB has approved the study Jefferson (M. Harper, faculty sponsor), An 
Examination of Cranial Electrotherapy Stimulation (CES) on Anxiety and Depressive 
Symptoms of Caregivers: A Double-Blind Experimental Study. If research 
participants have any questions about their rights as a research subject or concerns 
about this research study please contact the Chair, Institutional Review Board, St. 
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You may collect data from human subjects according to the approved research 
protocol. The approval stamp must appear on any Information Form or Informed 
Consent Form approved by the IRB (jpeg file attached). 
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Dan Ratliff, Ph.D. 
IRB Chair 
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Invitation to Participate in Research Study 
Dear Potential Participant, 
My name is Reginald Jefferson, and I am currently recruiting participants to be 
part of a study to increase understanding of the effectiveness an intervention designed to 
reduce stress in caregivers. To be eligible for the study, participants must be at least 18 
years old, live in the greater Houston area, and currently participate in a caregiving role 
for at least one person who is disabled, chronically ill, or cognitively impaired. As a 
caregiver you were a huge asset to this study. 
You were asked to complete a consent form and demographic information sheet 
before the study and stress-related symptoms questionnaires before and after the study. 
The study entails you using a device that is FDA approved to reduce stress, depression, 
insomnia, and anxiety. You were required to use it for 60 minutes a day for 3 weeks. The 
device is palm size, functional, and mobile, allowing for easy use. Using this device will 
not get in the way of caregiving responsibilities.  
There is no cost to you for participating in the study. However, you may 
experience benefits of relief from stress and anxiety symptoms. For participating in the 
study, you were entered in a drawing for a $50 VISA gift card.  
If you are willing to participate, please suggest a day and time when we can meet, 
and I will make myself available to you. If you have any questions, please don’t hesitate 
to ask. I can be reached at (713) 452-0614. 
Thank you,  





Informed Consent for Participation 
St. Mary’s University 
CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT 
Title: An Examination of Cranial Electrotherapy Stimulation (CES) 




Reginald Jefferson, MS, MA, NCC, LPC-S, LMFT 
Department of Counseling and Human Services 
St. Mary’s University 
(713) 452-0614 
I am being asked to participate in the above-named project. My participation in 
this study is entirely voluntary and I may refuse to participate or may decide to cease 
participation once the study has begun. Should I withdraw from this study, which I may 
do at any time, or should I refuse to participate in the study, my decision will involve no 
penalty or loss of benefits to which I am otherwise entitled. I am being asked to read the 
consent form carefully and were given a copy of it to keep. I was told the purpose of the 
study was to attempt to determine the effectiveness of an alternative method for reducing 
stress-related depressive and anxiety symptoms in caregivers. 
I was also informed of the following research procedures: First, I were asked to 
fill out a demographic information sheet about age, gender, ethnicity, marital status, 
work status, type of caregiver, length of time in a caregiver role, illnesses of care 
recipient(s), and annual income. Next, I were asked to fill out the State-Trait Anxiety 
Inventory and Beck’s Depression Inventory to assess for anxiety and depressive 





Appendix D (cont.) 
treatment and sham treatment. Neither I nor the researcher will know which 
group receives the active  
treatment. I am asked to follow the treatment protocol of use, which is one hour 
per day each day for three consecutive weeks. 
Every effort was made to maintain the confidentiality of my study records. I have been 
specifically told that the information gathered in this study were coded to protect my 
privacy and confidentiality. All data were coded with the number assigned to me at the 
beginning of the study. The list pairing participant names and participant numbers were 
kept separate from the data and will only be available to the principal investigator, 
Reginald Jefferson, MS, MA, LPC-S, LMFT. 
I have been advised that the data collected from the study were used for educational and 
publication purposes; however, I will not be identified by name. The confidentiality of the 
data was maintained within allowable legal limits. I have been told that the investigator 
has the right to withdraw me from this study at any time. 
The investigator has offered to answer all my questions. If I have additional questions 
during the course of this study about the research or any related issue, I may contact the 
principal investigator, Reginald Jefferson MS, MA, LPC-S, LMFT at (713) 452-0614 or 
via email reginaldjefferson@Stmarys.edu or you may contact Melanie Harper, Ph.D., St. 





Appendix D (cont.) 
My signature below acknowledges my voluntary participation in this research project. 
Such participation does not release the investigator, institution, or sponsor from their 
professional and ethical responsibilities to me. I have read the information provided 
above and had my questions answered to my satisfaction. I voluntarily agree to 
participate in this study. After it is signed, I will receive a copy of this consent form. 
 
______________________________________                                                                     
Name (Print)      
  
_______________________________________ __________________ 
Signature of Participant    Date 
 
_______________________________________ __________________ 
Signature of Principal Investigator   Date 
 
 
If you have any questions about your rights as a research subject or concerns about 
this research study please contact the Chair, Institutional Review Board, St. Mary’s 
University at 210-436-3736 or email at IRBCommitteeChair@stmarytx.edu. ALL 
RESEARCH PROJECTS THAT ARE CARRIED OUT BY INVESTIGATORS AT 
ST. MARY'S UNIVERSITY ARE GOVERNED BY THE REQUIREMENTS OF 









ID # ________________ 
Please do not write your name on this form. It were stored separately from any other 
information that you complete during this study and will not be linked with your 
responses in any way. The information will allow us to provide an accurate description of 
the sample.  
For the following items, please select the one response that is most descriptive of you or 







o Asian or Pacific Islander 
o Black/African American (Non-Hispanic) 
o Native American 
o Latino/Hispanic 
o Asian Indian 
o Caucasian/White 
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What is your marital status? 
o Single 








What type of caregiver are you? 
o Informal caregiver 
o Formal caregiver 
How long have you been in your caregiving role? 
o Less than 2 years 
o Two to 5 years 
o Greater than 5 years 
To what chronic illnesses do you provide care? 
o Alzheimer’s Disease 
o Dementia 
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o Cerebrovascular Accident (CVA) / Stroke 
o Cancer 
o Congestive Heart Failure 
o Mental Illness/Mental Retardation 
o HIV/AIDS 
o Other 
What is your annual income (Or combined income if you are married/cohabitating)? 
o Less than $30,000 
o $31,000 to $39,000 
o $40,000 to $ $49,000 
o $50,000 to $59,000 
o  $60,000 to $69,000 
o $70,000 to $79,000 
o $80,000 to $89,000 
o $90,000 to $99,000 










State-Trait Anxiety Inventory Sample and Permission Letter 
For use by Reginald Jefferson only. Received from Mind Garden, Inc. on March 28, 2015 
Self-Evaluation Questionnaire 
STAIAD Short Form Y-1 
Please provide the following information:  
Name      Date  
Age       Gender (Circle) M F Other 
Directions: A number of statements which people have used to describe themselves are 
given below. Read each statement and then circle the appropriate number to the right of 
the statement to indicate how you feel right now, that is, at this moment. There are no 
right or wrong answers. Do not spend too much time on any one statement but give the 
answer which seems to describe your present feelings best. Use the following scale:  
1)  NOT AT ALL  2) SOMEWHAT   3) MODERATELY SO   4) VERY MUCH SO            
1. I feel calm.............................................................................................. 1 2 3 4                                 
2. I am tense............................................................................................... 1 2 3 4                                  
3. I feel at ease........................................................................................... 1 2 3 4.                                
4. I am presently worrying over possible misfortunes ............................. 1 2 3 4                                   
5. I feel frightened..................................................................................... 1 2 3 4  
Copyright © 1968, 1977 by Charles D. Spielberger. All rights reserved in all media. 








Appendix F (cont.) 
For use by Reginald Jefferson only. Received from Mind Garden, Inc. on March 28, 2015 
To Whom It May Concern, 
 
The above-named person has made a license purchase from Mind Garden, Inc. and has 
permission to administer the following copyrighted instrument up to that quantity 
purchased: 
 
State-Trait Anxiety Inventory for Adults 
 
The four sample items only from this instrument as specified below may be included in 
your thesis or dissertation. Any other use must receive prior written permission from 
Mind Garden. The entire instrument may not be included or reproduced at any time in 
any other published material. Please understand that disclosing more than we have 
authorized will compromise the integrity and value of the test. Citation of the instrument 




I feel at ease 
I feel upset 
I lack self-confidence 
I am a steady person 
 
Copyright © 1968, 1977 by Charles D. Spielberger. All rights reserved in all media. 










CES Training Protocol 
Cranial Electrotherapy Stimulation Training Protocol 
1. You are asked to complete the 3-week protocol by using your device each day 
consecutively for the entire 3-week period.  
2. The CES device has been preset to run for 60 minutes each time you use it.  
3. The manufacturer has preset each device to be active or sham as this is part of the 
blinding process. Until the study ends, the researcher does not know which 
devices are set to be active or sham. 
4. To use your device, place one drop of saline solution on each ear clip. 
5. Place an ear clip on each ear lobe 
6. Turn device on. 
7. Press Start and let run for 60 minutes. 
8. After the device shuts off, remove the clips from your ear lobes. 
9. Record daily participation on the tracking sheet. 
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